key: cord-0935683-ar71yz2k authors: Eisma, Maarten C.; Tamminga, Aerjen; Smid, Geert E.; Boelen, Paul A. title: Acute Grief after Deaths due to COVID-19, Natural Causes and Unnatural Causes: An Empirical Comparison date: 2020-09-13 journal: J Affect Disord DOI: 10.1016/j.jad.2020.09.049 sha: d4e2f13312e07853d78d952fcd294e7e75ec8ce9 doc_id: 935683 cord_uid: ar71yz2k BACKGROUND: There are now over 800,000 registered deaths due to the COVID-19 pandemic worldwide. Researchers have suggested that COVID-19 death characteristics (e.g., intensive care admission, unexpected death) and circumstances (e.g., secondary stressors, social isolation) will precipitate a worldwide increase of prolonged grief disorder (PGD) and persistent complex bereavement disorder (PCBD). Yet, no study has investigated this. Since acute grief is a strong predictor of future pathological grief, we compared grief levels among people recently bereaved due to COVID-19, natural, and unnatural causes. METHODS: People bereaved through COVID-19 (n = 49), natural causes (n = 1182), and unnatural causes (n = 210), completed self-report measures of demographic and loss-related characteristics and PGD and PCBD symptoms. RESULTS: COVID-19 bereavement yielded higher symptom levels of PGD (d = 0.42) and PCBD (d = 0.35) than natural bereavement (but not unnatural bereavement). Effects held when limiting analyses to recent losses and those who participated during the pandemic. Expectedness of the death explained this effect. LIMITATIONS: Limitations include using a convenience sample and self-report measures. CONCLUSIONS: Higher grief levels occur among people bereaved due to COVID-19 compared to people bereaved due to natural loss. We predict that pandemic-related increases in pathological grief will become a worldwide public health concern.  COVID-19 bereavement yields higher grief levels than natural bereavement  COVID-19 bereavement does not yield higher grief levels than unnatural bereavement  Death expectedness explains grief variation between COVID-19 and natural bereavement admission, unexpected death) and circumstances (e.g., secondary stressors, social isolation) will precipitate a worldwide increase of prolonged grief disorder (PGD) and persistent complex bereavement disorder (PCBD). Yet, no study has investigated this. Since acute grief is a strong predictor of future pathological grief, we compared grief levels among people recently bereaved due to COVID-19, natural, and unnatural causes. People bereaved through COVID-19 (n = 49), natural causes (n = 1182), and unnatural causes (n = 210), completed self-report measures of demographic and loss-related characteristics and PGD and PCBD symptoms. COVID-19 bereavement yielded higher symptom levels of PGD (d = 0.42) and PCBD (d = 0.35) than natural bereavement (but not unnatural bereavement). Effects held when limiting analyses to recent losses and those who participated during the pandemic. Expectedness of the death explained this effect. Limitations include using a convenience sample and self-report measures. Higher grief levels occur among people bereaved due to COVID-19 compared to people bereaved due to natural loss. We predict that pandemic-related increases in pathological grief will become a worldwide public health concern. Keywords: Coronavirus; COVID-19; grief; bereavement; prolonged grief disorder The COVID-19 pandemic is a health crisis unparalleled in recent history. With currently 23,057,288 confirmed cases and 800,906 confirmed deaths worldwide (World Health Organization, 2020), its impact exceeds even the most devastating natural disasters of previous decades, including the South-East Asia Tsunami and the Haiti Earthquake. Researchers have predicted that the circumstances and characteristics of COVID-19 related deaths will lead to a worldwide rise in severe, persistent, and disabling grief reactions, termed Specifically, experiencing a sudden loss, in intensive care, combined with exposure to multiple secondary stressors (e.g., infection, social isolation, job loss) has been argued to elicit severe grief reactions in those experiencing bereavement due to COVID-19 (e.g., Eisma et al., 2020; Kokou-Kpolou et al., 2020; Morris et al., 2020) . Moreover, government policy to reduce the spread of COVID-19 (e.g., social distancing, quarantine) may yield additional stress, as it may affect death rituals and social support, thereby hampering the grief process . The projected rise of disturbed grief during the pandemic is expected to precipitate a heightened need for remotely delivered treatments for PGD and PCBD, including therapy delivered via internet platforms and videoconferencing (e.g., . Despite the clinical importance of the topic, no research has yet examined bereavement due to pandemics, let alone the health consequences of bereavement due to COVID-19 (Mayland et al., 2020) . Specific learning on COVID-19 and the impact of bereavement is therefore pertinent. Accordingly, the present study examined acute grief reactions in people bereaved due to COVID-19 and compared these with grief among people who have experienced unnatural and natural loss. Acute grief is among the strongest predictors of the development of PGD (e.g., and the time criteria of PGD (6 months post-loss) and PCBD (12 months post-loss) preclude the establishment of diagnoses among those recently bereaved due to COVID-19. Therefore, the study of acute grief is presently most informative to ascertain if disturbed grief prevalence will rise due to the pandemic. A local ethics committee approved the present ongoing study. Adult bereaved participants were recruited on a website containing an online self-test for PCBD. Prior to study participation, participants were given information about the study procedure and background (e.g., study aims, data handling, and voluntariness). All participants provided informed consent. After filling in the survey, participants received a preliminary indication if they met criteria for PCBD (including information on its time-criterion and the message that only a licensed professional can establish diagnoses). The self-test included an assessment of demographic characteristics ( Before the analyses, duplicates (n = 78), non-adults (n = 117), and those labelling the cause of loss as "different" (n = 208), were removed from the dataset, leaving 1441 participants. We compared between participants who experienced COVID-19-related bereavement (n = 49), natural loss (n = 1182), and unnatural loss (i.e., accident, suicide, homicide, n = 210). We examined differences between groups on demographic and loss-related variables and symptom levels using Fisher's exact test for categorical variables and ANOVAs (with LSD post-hoc tests) for continuous variables. We performed analyses in SPSS 25.0 and applied a two-sided significance level of .05. Table 1 Study limitations included our reliance on convenience sampling and self-report measures, and considering a limited set of demographic and loss-related characteristics in our group comparisons. Nevertheless, this is the very first study demonstrating that more severe acute grief reactions occur after COVID-19-related bereavement compared to natural bereavement (but not unnatural bereavement). Our research further suggests that expectedness of the death explains differences in grief between people experiencing COVID-19-related and natural loss. Since acute grief is a strong longitudinal predictor of PGD , our findings strengthen predictions of grief researchers that disturbed grief will become a worldwide health concern during this pandemic and that remotely delivered grief treatments should be developed, tested and implemented. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. ME and AT developed the study concept; AT gathered the data; ME conducted the data preparation and analyses; ME drafted the first version of the manuscript; AT, GS and PB added important intellectual content and contributed to revisions of the manuscript and approved the final version for submission. The authors declare that there is no conflict of interest regarding the publication of this article. F(2, 688) = 5.51*, C > N*, U > N* F(2, 688) = 6.90**, C > (Mean (SD)) (6.39) (8.15) (7.71) N*, U > N* Grief levels PCBD during pandemic (Mean (SD)) Grief levels PGD during pandemic (Mean (SD)) 57.37 (9.60) 38.94 (6.39) 57.96 (9.65) 38.92 (6.84) 53.08 (10.82) 35.36 (7.70) F(2, 592) = 9.71**, C > N*, U > N** F(2, 592) = 11.30**, C > N*, U > N** Note. C = COVID-19 loss; U = unnatural loss, N = natural loss. * p < .05, ** p < .001. Remotely delivered cognitive behavior therapy for disturbed grief during the COVID-19 crisis: Challenges and opportunities Symptoms of prolonged grief, posttraumatic stress, and depression in recently bereaved people: Symptom profiles, predictive value and cognitive-behavioral correlates The Traumatic Grief Inventory Self-Report version (TGI-SR): Introduction and preliminary psychometric evaluation Prolonged grief disorder following the Coronavirus (COVID-19) pandemic Prolonged grief related to COVID-19 deaths: Do we have to fear a steep rise in traumatic and disenfranchised griefs? Supporting adults bereaved through COVID-19: A rapid review of the impact of previous pandemics on grief and bereavement Caring for bereaved family members during the COVID-19 pandemic: Before and after the death of a patient Prolonged grief disorder: Psychometric validation of criteria proposed for DSM-V and ICD-11 World Health Organization None. American Psychiatric Association, 2013. Diagnostic and statistical manual of mental disorders : DSM-5. American Psychiatric Association, DSM.